Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Coenzyme Q10 in Huntington's Disease (HD)

NCT00608881 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00608881 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Coenzyme Q10 in Huntington's Disease (HD)
Lead sponsor
Massachusetts General Hospital
Phase
Phase 3
Overall status
Terminated
Start date
March 31, 2008
Completion date
May 31, 2015
Enrollment
609 (actual)
Sites
49

Conditions

As the registry lists them; a condition with its own page is linked.

huntington's disease